Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.

Saved in:
Bibliographic Details
Title: Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.
Authors: Zeidan AM; Section of Hematology, Department of Medicine, Yale School of Medicine, and Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT. Electronic address: amer.zeidan@yale.edu., Joshi N; OPEN Health, Bethesda, MD., Kale H; OPEN Health, Bethesda, MD., Wang WJ; OPEN Health, Bethesda, MD., Corman S; OPEN Health, Bethesda, MD., Salimi T; Taiho Oncology Inc., Princeton, NJ., Epstein RS; Epstein Health LLC, Woodcliff Lake, NJ.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Sep; Vol. 22 (9), pp. 670-679. Date of Electronic Publication: 2022 Apr 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2152-2669
DOI:10.1016/j.clml.2022.04.016